Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.
Arthritis Rheum. 2010 May;62(5):1290-7. doi: 10.1002/art.27383.
Arthritis Rheum. 2010.
PMID: 20461780
Clinical Trial.